P01.04 Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

P Jänne,C Baik,H Hayashi,W Su,Z Qi,K Enomoto,M Karnoub,C Yu,Y Qiu,H.A Yu

doi:10.1016/j.jtho.2021.01.328

P01.04 Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

P Jänne, C Baik + Show 8 more

Open Access

https://doi.org/10.1016/j.jtho.2021.01.328

Copy DOI

Journal: Journal of Thoracic Oncology	Publication Date: Mar 1, 2021
License type: publisher-specific-oa

Affiliation: Dana-Farber Cancer Institute, Seattle Cancer Care Alliance, Kindai University Hospital, National Cheng Kung University Hospital, Daiichi Sankyo (United States), Daiichi Sankyo (Germany), Daiichi-Sankyo (Japan)

#EGFR-Mutated NSCLC Patients #EGFR-Mutated NSCLC + Show 2 more

Abstract
Full-Text PDF
Similar Papers

Abstract

P01.04 Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Thoracic Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.